The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 7, 2007, Pages 760-765

  Fimognari, Filippo Luca ^a,b,e   Pasqualetti, Patrizio ^c   Moro, Leo ^b   Franco, Alessandro ^a   Piccirillo, Gianfranco ^d   Pastorelli, Ruggero ^a   Rossini, Paolo Maria ^c   Incalzi, Raffaele Antonelli ^b  

^a Leopoldo Parodi Delfino Hospital   (Italy)

^b Casa di Cura Merry House   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPIROMETRY; WAIST CIRCUMFERENCE; BREATHING DISORDER; CROSS-SECTIONAL STUDY; LUNG FUNCTION TEST; PHYSIOLOGY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; RESPIRATION DISORDERS; RESPIRATORY FUNCTION TESTS;

EID: 34548385683     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.7.760     Document Type: Article

References (37)

1. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996;313:711-715.
2. Zureik M, Kauffmann F, Touboul PJ, Courbon D, Ducimetiere P. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med. 2001;161:1669-1676.
3. Engstrom G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk. Relationship with inflammatory-sensitive plasma proteins. Circulation. 2002;106:2555-2560.
4. Engstrom G, Wollmer P, Valind S, Hedblad B, Janzon L. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914'. J Hypertens. 2001;19:1203-1208.
5. Lazarus R, Sparrow D, Weiss ST. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Resp J. 1998;12:641-645.
6. Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253:574-581.
7. Engstrom G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med. 2002;19:167-170.
8. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes. Diabetes Care. 2005;28:1472-1479.
9. Lazarus R, Sparrow D, Weiss ST. Impaired ventilatory function and elevated insulin levels in nondiabetic males: the Normative Aging Study. Eur Resp J. 1998;12:635-640.
10. Lawlor DA, Ebrahim S, Davey-Smith G. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia. 2004;47:195-203.
11. Burchfiel CM, Curb JD, Sharp DS, et al. Distribution and correlates of insulin in elderly men. Arterioscler Thromb Vasc Biol. 1995;5:2213-2221.
12. Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its association with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2000;50:153-159.
13. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003; 58:388-393.
14. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med. 2006;100:115-122.
15. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med. 2003;254:540-547.
16. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med. 2003;114:758-762.
17. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes. Findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. Diabetes Care. 2004;27:2966-2970.
18. Scuteri A, Najjar SS, Morrell CH, Lakatta ES. The metabolic syndrome in older individuals: prevalence and prediction of Cardiovascular Health Study. Diabetes Care. 2005;28:882-887.
19. Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institutes of Health (NIH); NIH publication, N. 02-3659, 2003 document (2004 update), Chapter 5, pp. 67-71.
20. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Resp Dis. 1983;127:725-734.
21. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD scientific committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global initiative for chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Resp Crit Care Med. 2001;163:1256-1276.
22. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-magnesium precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem. 1982;28:1379-1382.
23. Tietz NW, ed. Clinical Guide to Laboratory Tests, 2nd Ed. Philadelphia: WB Saunders; 1990:333.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
25. National Institutes of Health. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;85:2486-2496.
26. Classification Committee of WONCA. International Classification of Health Problems in Primary Care (ICHPPC)-2-Defined. 3rd Ed. Oxford, U.K.: Oxford University Press; 1983.
27. Mannino DM, Holguin F, Pavlin BI, Ferdinands JM. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow up. Int J Tuberc Lung Dis. 2005;9:613-621.
28. Fimognari FL, Pastorelli R, Scarlata S, Incalzi RA. Restrictive ventilatory dysfunction and dyspnea in elderly subjects. Am J Med. 2005;118:1300-1301.
29. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567-572.
30. Arboix A, Morcillo C, Garcia-Eroles L, Oliveres M, Massons J, Targa C. Different vascular risk factor profiles in ischemic stroke subtypes: a study from the "Sagrat Cor Hospital of Barcelona Stroke Registry". Acta Neurol Scand. 2000;102:264-270.
31. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-1012.
32. Basili S, Ferroni P, Vieri M, et al. Lipoprotein (a) serum levels in patients affected by chronic obstructive pulmonary disease. Atherosclerosis. 1999;147:249-252.
33. Sin DD, Man P. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514-1519.
34. Davì G, Basili S, Vieri M, et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 1997;156:1794-1799.
35. Praticò D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alfa-III, an index of oxidant stress. Am J Respir Crit Care Med. 1998;158:1709-1714.
36. Alessandri C, Basili S, Violi F, Ferroni P, Gazzaniga PP, Cordova C. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb Haemostas. 1994;72:343-346.
37. Aaron SD, Dales R, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest. 1999;115:869-887.